- Scientists have developed a new drug that targets two key regions of the tau protein, a major contributor to Alzheimer’s disease.
- The drug, a peptide inhibitor called RI-AG03, successfully prevented the build-up of toxic tau proteins in both laboratory and fruit fly studies.
- Although further research is necessary, including clinical trials in humans, this research contributes to the advancement of more effective therapies for neurodegenerative diseases.
Tau proteins are essential for…
Read the full article here